145 related articles for article (PubMed ID: 26579796)
1. Genetic Association Between CDKN1B rs2066827 Polymorphism and Susceptibility to Cancer.
Lu Y; Gao K; Zhang M; Zhou A; Zhou X; Guan Z; Shi X; Ge S
Medicine (Baltimore); 2015 Nov; 94(46):e1217. PubMed ID: 26579796
[TBL] [Abstract][Full Text] [Related]
2. Association of CDKN1B gene polymorphisms with susceptibility to breast cancer: a meta-analysis.
Xiang H; Li H; Ge W; Wu W; Gao M; Wang W; Hong L; Jiang D; Zhang C
Mol Biol Rep; 2013 Nov; 40(11):6371-7. PubMed ID: 24078094
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between cyclin-dependent kinase inhibitor 1B rs2066827 polymorphism and breast cancer susceptibility.
Jia ZM; Liu Y; Cui SY
Tumour Biol; 2014 Jun; 35(6):5527-31. PubMed ID: 24523023
[TBL] [Abstract][Full Text] [Related]
4. Genetic association between the cyclin-dependent kinase inhibitor gene p27/Kip1 polymorphism (rs34330) and cancer susceptibility: a meta-analysis.
Cheng XK; Wang XJ; Li XD; Ren XQ
Sci Rep; 2017 Mar; 7():44871. PubMed ID: 28317869
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
6. Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.
Landa I; Montero-Conde C; Malanga D; De Gisi S; Pita G; Leandro-García LJ; Inglada-Pérez L; Letón R; De Marco C; Rodríguez-Antona C; Viglietto G; Robledo M
Endocr Relat Cancer; 2010 Jun; 17(2):317-28. PubMed ID: 20075119
[TBL] [Abstract][Full Text] [Related]
7. CDKN1B Val 109 Gly variant is not related to risk of prostate cancer.
Zhu L; Wang J; Yue C; Yuan W; Zhang W; Shi L; Mi Y; Wu X; Zhang LF; Zuo L
J Cell Biochem; 2019 Oct; 120(10):18346-18356. PubMed ID: 31257659
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-17F T7488C polymorphism in carcinogenesis: a meta-analysis.
Yao F; Yan S; Wang X; Shi D; Bai J; Li F; Sun B; Qian B
Tumour Biol; 2014 Sep; 35(9):9061-8. PubMed ID: 24913709
[TBL] [Abstract][Full Text] [Related]
9. Association between HIF-1α C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studies.
Yan Q; Chen P; Wang S; Liu N; Zhao P; Gu A
BMC Cancer; 2014 Dec; 14():950. PubMed ID: 25496056
[TBL] [Abstract][Full Text] [Related]
10. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
Ma C; Liu Y; Zhang W; Liu P
Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
[TBL] [Abstract][Full Text] [Related]
11. The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies.
Zou P; Gu A; Ji G; Zhao L; Zhao P; Lu A
BMC Cancer; 2012 Jan; 12():7. PubMed ID: 22221621
[TBL] [Abstract][Full Text] [Related]
12. p27(Kip1) V109G polymorphism and cancer risk: a systematic review and meta-analysis.
Wei F; Xu J; Tang L; Shao J; Wang Y; Chen L; Guan X
Cancer Biother Radiopharm; 2012 Dec; 27(10):665-71. PubMed ID: 22823061
[TBL] [Abstract][Full Text] [Related]
13. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-Activated Protein Kinase Kinase 4 Gene Polymorphism and Cancer Risk.
Geng P; Ou J; Xie G; Li J; Zhao X; Xiang L; Liao Y; Wang N; Liang H
Medicine (Baltimore); 2015 Nov; 94(44):e0938. PubMed ID: 26554761
[TBL] [Abstract][Full Text] [Related]
15. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women.
Cai H; Xiang YB; Qu S; Long J; Cai Q; Gao J; Zheng W; Shu XO
Am J Epidemiol; 2011 Jun; 173(11):1263-71. PubMed ID: 21454826
[TBL] [Abstract][Full Text] [Related]
17. MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies.
Wang J; Wang B; Bi J; Li K; Di J
J Cancer Res Clin Oncol; 2012 Jun; 138(6):979-89. PubMed ID: 22358302
[TBL] [Abstract][Full Text] [Related]
18. P21 Ser31Arg polymorphism and cervical cancer risk: a meta-analysis.
Li Y; Liu F; Tan S; Li S
Int J Gynecol Cancer; 2011 Apr; 21(3):445-51. PubMed ID: 21430453
[TBL] [Abstract][Full Text] [Related]
19. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.
Xia L; Gao J; Liu Y; Wu K
Tumour Biol; 2013 Feb; 34(1):223-30. PubMed ID: 23055196
[TBL] [Abstract][Full Text] [Related]
20. The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.
Yu Z; Liu Q; Huang C; Wu M; Li G
OMICS; 2013 Apr; 17(4):200-14. PubMed ID: 23574339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
